Abstract
We studied the effects of acute glycemia on plasma nitric oxide (NO; nitrite plus nitrate) levels, Cu-Zn Superoxide dismutase (Cu-Zn SOD) activity and thiobarbituric acid-reactive substances (TBARS) levels in age-matched female subjects before and tow hours after glucose loading. According to the results of glucose loading, subjects were divided in the three groups as normal (n = 13, NGT), impaired (n = 11, IGT) and diabetic glucose tolerance (n = 10, DGT). Plasma NO levels were significantly higher in subjects with DGT than in subjects with NGT (p < 0.001) and IGT (p < 0.05) at baseline. Two hours after glucose loading, plasma NO levels were significantly decreased in subjects with IGT and DGT (p < 0.001 and p < 0.001). Although plasma TBARS levels in subject with NGT did not change from the baseline levels after glucose loading, TBARS levels were significantly elevated in subjects with DGT and IGT (p < 0.001 and p < 0.001). Plasma Cu-Zn SOD activities were within a similar range in all subjects at baseline. Cu-Zn SOD activities were significantly increased in subjects with NGT, and were significantly decreased in subjects with IGT and DGT (p < 0.001 and p < 0.001) after glucose loading. There was a positive correlation between NO and glucose in subjects with NGT (r = 0.34, p < 0.01) and a negative correlation between NO and TBARS in IGT sum DGT during glucose tolerance (r = - 0.38, p < 0.01). We suggest that NO availability was decreased when the blood glucose levels were only moderately elevated above normal levels. This might be related with the enhanced oxidative stress.
Key words
Oral glucose tolerance test - Oxidative stress - Atherosclerosis - Nitric oxide - Glucose loading
References
-
1
Haffner S M.
The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.
Endocrine Reviews.
1998;
19
583-592
-
2
Baron A D.
Impaired glucose tolerance as a disease.
Am J Cardiol.
2001;
88
16H-19H
-
3
Higashi K, Shige H, Ito T, Nakajima K, Ishikawa T, Nakamura H, Ohsuzu F.
Impaired glucose tolerance without hypertriglyceridemia does not enhance postprandial lipemia.
Horm Metab Res.
2001;
33
101-105
-
4
Balletshofer B M, Rittig K, Volk A, Maerker E, Jacob S, Rett K, Haring H.
Impaired non-esterified fatty acid suppression is associated with endothelial dysfunction in insulin resistant subjects.
Horm Metab Res.
2001;
33
428-431
-
5
Thalhammer C, Balzuweit B, Busjahn A, Walter C, Luft F C, Haller H.
Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbed carbohydrate metabolism in patients at risk for cardiovascular disease.
Thromb Vasc Biol.
1999;
19
1173-1179
-
6
Arshed A, Quyyumi M D.
Endothelial function in health and disease: New Insights in to genesis ofcardiovascular disease.
Am J Med.
1998;
105
32S-38S
-
7
Tomiyama H, Kimura Y, Okazaki R, Kushiro T, Abe M, Kuwabara Y, Yoshida H. et al .
Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension.
Hypertension.
2000;
36
245-249
-
8 WHO Study Group on Diabetes. WHO Technical Report Series 727. Geneva; World Health Organization 1985
-
9
Ghrisman M B, Johnson G G, Lancaster J R.
Quantitation of nitrate and nitrite in extracellular fluids.
Methods Enzymol.
1996;
268
237-247
-
10
Sun Y, Oberley L W, Li Y A.
Simple method for clinical assay of superoxide dismutase.
Clin Chem.
1988;
34
497-500
-
11
Buege J A, Aust D S.
Microsomal lipid peroxidation.
Methods Enzymol.
1978;
52
302-310
-
12
Watts G F, Playfold D A.
Dislipoproteinemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: a Hypothesis.
Atherosclerosis.
1998;
141
17-30
-
13
Vehkavaara S, Seppala-Lindroos A, Westerbacka J, Groop P H, YkI-Jarvinen H.
ln vivo endothelial dysfunction characterizes patients with impaired-fasting glucose.
Diabetes Care.
1999;
22
2055-2060
-
14
Lefebvre P J, Scheen A J.
The postprandial state and risk of cardiovascular disease.
Diabet Med.
1998;
15
563-568
-
15
Johnstone M T, Creager S J, Scales K M, Cusco J A, Lee B K, Creager M A.
Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus.
Circulation.
1993;
88
2510-2516
-
16
Elliot T G, Cockcroft J R, Groop P H, Viberti G C, Ritter J M.
Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria.
Clin Sci.
1993;
85
687-693
-
17
Houben A JHM, Schaper N C, de Haan cha, Hovers F C, Slaaf D W, de Leeuw P W, Nieuwenhuijzen K AC.
Local 24-h hyperglycemia does not affect endothelium-dependent or-independent vasoreactivity in humans.
Am J Physiol Heart Circ Physiol.
1996;
270
H 2014-H 2020
-
18
Lambert J, Aarsen M, Donker A J, Stehouwer C D.
Endothelium-dependent and independent vasodilatation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus.
Arterioscler Vasc Biol.
1996;
16
705-711
-
19
Graier W F, Wascher T C, Lackner L, Toplak H, Krejs G J, Kukovetz W R.
Exposure to elevated D-glucose concentration modulates vascular endothelial cell vasodilatory response.
Diabetes.
1993;
42
1497-1505
-
20
Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, Nakagawa A, Kigoshi T, Ishibashi T, Nishio M, Uchida K.
Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects; Relationship to microvascular complications.
J Diabetes Complications.
2001;
15
135-143
-
21
Wascher T C, Graier W F, Bahadori B, Toplak H.
Time course of endothelial dysfunction in diabetes mellitus.
Circulation.
1994;
90
1109-1110
-
22
Ding Y, VazirI N D, Coulson R, Kamanna V S, Roh D D.
Effects of simulated hyperglycemia, insulin, and glucagons on endothelial nitric oxide synthase expression.
Am J Physiol Endocrinol Metab.
2000;
279
E11-E17
-
23
Jeremy J Y, Yim A P, Wan S, Angelini G D.
Oxidative stress, nitric oxide, and vascular disease.
J Card Surg.
2002;
17
324-327
-
24
Li H, Förstermann U.
Nitric oxide in pathogenesis of vascular disease.
J Pathol.
2000;
190
224-254
-
25
Graier W F, Posch K, Wascher T C, Kostner G M.
Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia.
Horm Metab Res.
1997;
29
622-626
-
26
Bayraktutan U.
Free radicals, diabetes and endothelial dysfunction.
Diabetes Obes Metab.
2002;
4
224-238
Prof. Dr. D. Konukoğlu, M. D.
Fatih Sitesi, B-4 Blok, Daire 5, SilivrikapI, Fatih, Istanbul, Turkey ·
Email: dkonuk@yahoo.com
